{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:51:22Z","timestamp":1794001882463,"version":"4.8.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["223500\/Z\/21\/Z"],"award-info":[{"award-number":["223500\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.blre.2024.101194","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T12:32:55Z","timestamp":1710851575000},"page":"101194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The acute pain crisis in sickle cell disease: What can be done to improve outcomes?"],"prefix":"10.1016","volume":"65","author":[{"given":"Paul","family":"Telfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi A.","family":"Anie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Kotsiopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Aiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Stuart-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Lugthart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2024.101194_bb0005","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2024.101194_bb0010","author":"All Party Parliamentary Group"},{"key":"10.1016\/j.blre.2024.101194_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4063","article-title":"Management of an acute painful sickle cell episode in hospital: summary of NICE guidance","volume":"344","author":"Gillis","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2024.101194_bb0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2024.101194_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012187.pub2","article-title":"Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults","author":"Cooper","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.blre.2024.101194_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003350.pub2","article-title":"Pain management for sickle cell disease","author":"Dunlop","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.blre.2024.101194_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(23)00182-5","article-title":"Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective","volume":"10","author":"Manu Pereira","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.blre.2024.101194_bb0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.24612","article-title":"Daily pain in adults with sickle cell disease-a different perspective","volume":"92","author":"van Tuijn","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2024.101194_bb0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5055\/jom.2015.0273","article-title":"Daily home opioid use in adults with sickle cell disease: The PiSCES project","volume":"11","author":"Smith","year":"2015","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.blre.2024.101194_bb0050","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jama.2019.9794","article-title":"Lessons learned from the opioid epidemic","volume":"322","author":"Sharfstein","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2024.101194_bb0055","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1016\/S2352-3026(22)00144-2","article-title":"Sickle cell disease: a year in review","volume":"9","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.blre.2024.101194_bb0060","article-title":"A non-injected opioid analgesia protocol for acute pain crisis in adolescents and adults with sickle cell disease","volume":"0","author":"Telfer","year":"2024","journal-title":"Br J Pain"},{"key":"10.1016\/j.blre.2024.101194_bb0065","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.annemergmed.2020.08.006","article-title":"A multiyear cross-sectional study of guideline adherence for the timeliness of opioid administration in children with sickle cell pain crisis","volume":"76","author":"Brousseau","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.blre.2024.101194_bb0070","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1553-2712.2007.tb01801.x","article-title":"Emergency department management of acute pain episodes in sickle cell disease","volume":"14","author":"Tanabe","year":"2007","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.blre.2024.101194_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28268","article-title":"The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain","volume":"67","author":"Muslu","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2024.101194_bb0080","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ajh.24534","article-title":"Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease","volume":"91","author":"Brandow","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2024.101194_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27274","article-title":"A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department","volume":"65","author":"Schefft","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2024.101194_bb0090","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2218","article-title":"Improving care for sickle cell pain crisis using a multidisciplinary approach","volume":"143","author":"Balsamo","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.blre.2024.101194_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27420","article-title":"Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis","volume":"65","author":"Payne","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2024.101194_bb0100","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/pm\/pnab092","article-title":"Implementation of individualized pain care plans decreases length of stay and hospital admission rates for high utilizing adults with sickle cell disease","volume":"22","author":"Welch-Coltrane","year":"2021","journal-title":"Pain Med"},{"key":"10.1016\/j.blre.2024.101194_bb0105","author":"Public Digital"},{"key":"10.1016\/j.blre.2024.101194_bb0110","author":"London care record (Cerner HIE) Access"},{"key":"10.1016\/j.blre.2024.101194_bb0115","doi-asserted-by":"crossref","DOI":"10.2196\/24818","article-title":"Electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease: protocol for a preimplementation and postimplementation study","volume":"10","author":"Luo","year":"2021","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.blre.2024.101194_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.24948","article-title":"A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)","volume":"93","author":"Tanabe","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2024.101194_bb0125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/ejh.13924","article-title":"Time to pain relief: A randomized controlled trial in the emergency department during vaso-occlusive episodes in sickle cell disease","volume":"110","author":"Tanabe","year":"2023","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2024.101194_bb0130","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/acem.14805","article-title":"A comparison of the effect of patient-specific versus weight-based protocols to treat vaso-occlusive episodes in the emergency department","volume":"30","author":"Tanabe","year":"2023","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.blre.2024.101194_bb0135","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2146\/ajhp140630","article-title":"Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings","volume":"72","author":"Corrigan","year":"2015","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.blre.2024.101194_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/jocmr4841","article-title":"Improving the Emergency Department Management of Sickle Cell Vaso-Occlusive Pain Crisis: The Role and Options of Sublingual and Intranasally Administered Analgesia","volume":"15","author":"Ojo","year":"2023","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.blre.2024.101194_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26332","article-title":"Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease","volume":"64","author":"Fein","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2024.101194_bb0150","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/papr.12313","article-title":"Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease","volume":"16","author":"De Franceschi","year":"2016","journal-title":"Pain Pract"},{"key":"10.1016\/j.blre.2024.101194_bb0155","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.ajem.2017.11.015","article-title":"Intranasal fentanyl improves time to analgesic delivery in sickle cell pain crises","volume":"36","author":"Kelly","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.blre.2024.101194_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25144","article-title":"Impact of intranasal fentanyl in nurse initiated protocols for Sickle Cell Vaso-occlusive pain episodes in a pediatric emergency department","author":"Akinsola","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2024.101194_bb0165","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/adc.2008.138875","article-title":"Intranasal diamorphine for acute sickle cell pain","volume":"94","author":"Telfer","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.blre.2024.101194_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101728","article-title":"Evaluation of a non-parenteral opioid analgesia protocol for acute sickle cell pain episodes in children","volume":"8","author":"Telfer","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.blre.2024.101194_bb0175","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ajh.26837","article-title":"Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: A multicenter pediatric emergency medicine perspective","volume":"98","author":"Rees","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2024.101194_bb0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/20494637211033814","article-title":"A non-injected opioid analgesia protocol for acute pain crisis in adolescents and adults with sickle cell disease","volume":"16","author":"Telfer","year":"2022","journal-title":"Br J Pain"},{"key":"10.1016\/j.blre.2024.101194_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40262-012-0016-7","article-title":"Pharmacokinetics of non-intravenous formulations of fentanyl","volume":"52","author":"Lotsch","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.blre.2024.101194_bb0190","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(97)08462-6","article-title":"Randomised trial of oral morphine for painful episodes of sickle-cell disease in children","volume":"350","author":"Jacobson","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2024.101194_bb0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clpt.2003.10.007","article-title":"Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease","volume":"75","author":"Kopecky","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.blre.2024.101194_bb0200","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2147\/JPR.S343069","article-title":"Moving toward a multimodal analgesic regimen for acute Sickle Cell pain with non-opioid analgesic adjuncts: a narrative review","volume":"15","author":"Kenney","year":"2022","journal-title":"J Pain Res"},{"key":"10.1016\/j.blre.2024.101194_bb0205","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ajh.25471","article-title":"Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain","volume":"94","author":"Carden","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2024.101194_bb0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/acem.14382","article-title":"Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial","volume":"29","author":"Alshahrani","year":"2022","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.blre.2024.101194_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30254","article-title":"Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease","volume":"70","author":"Harris","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2024.101194_bb0225","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1093\/pm\/pnac094","article-title":"Early initiation of sub-anesthetic ketamine infusion in adults with vaso-occlusive crises is associated with greater reduction in sickle cell pain intensity: a single center\u2019s experience","volume":"23","author":"Kenney","year":"2022","journal-title":"Pain Med"},{"key":"10.1016\/j.blre.2024.101194_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/sjpain-2017-0140","article-title":"Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial","volume":"18","author":"Lubega","year":"2018","journal-title":"Scand J Pain"},{"key":"10.1016\/j.blre.2024.101194_bb0235","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2147\/JPR.S131156","article-title":"Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study","volume":"10","author":"Sheehy","year":"2017","journal-title":"J Pain Res"},{"key":"10.1016\/j.blre.2024.101194_bb0240","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/pr.2017.197","article-title":"Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease","volume":"83","author":"Nobrega","year":"2018","journal-title":"Pediatr Res"},{"key":"10.1016\/j.blre.2024.101194_bb0245","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jha2.188","article-title":"Gabapentin for acute pain in sickle cell disease: A randomized double-blinded placebo-controlled phase II clinical trial","volume":"2","author":"Puri","year":"2021","journal-title":"EJHaem"},{"key":"10.1016\/j.blre.2024.101194_bb0250","first-page":"5","article-title":"Intravenous acetaminophen for the Management of Pain during Vaso-occlusive Crises in pediatric patients","volume":"44","author":"Baichoo","year":"2019","journal-title":"P T"},{"key":"10.1016\/j.blre.2024.101194_bb0255","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/acem.14149","article-title":"Does intravenous acetaminophen reduce opioid requirement in pediatric emergency department patients with acute Sickle Cell crises?","volume":"28","author":"Dhebaria","year":"2021","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.blre.2024.101194_bb0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pmn.2020.02.069","article-title":"The effect of progressive muscle relaxation exercises on pain on patients with Sickle Cell disease: randomized controlled study","volume":"22","author":"Kazak","year":"2021","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.blre.2024.101194_bb0265","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jmt\/thy004","article-title":"The effects of a single electronic music improvisation session on the pain of adults with Sickle Cell disease: a mixed methods pilot study","volume":"55","author":"Rodgers-Melnick","year":"2018","journal-title":"J Music Ther"},{"key":"10.1016\/j.blre.2024.101194_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5539004","article-title":"A randomized clinical hypnosis pilot study: improvements in self-reported pain impact in adults with Sickle Cell disease","volume":"2021","author":"Wallen","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.blre.2024.101194_bb0275","article-title":"Psychological therapies for sickle cell disease and pain","volume":"2015","author":"Anie","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.blre.2024.101194_bb0280","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.NAJ.0000445680.06812.6a","article-title":"Original research: using guided imagery to manage pain in young children with sickle cell disease","volume":"114","author":"Dobson","year":"2014","journal-title":"Am J Nurs"},{"key":"10.1016\/j.blre.2024.101194_bb0285","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/AJP.0000000000000183","article-title":"Changes in coping, pain, and activity after cognitive-behavioral training: a randomized clinical trial for pediatric sickle cell disease using smartphones","volume":"31","author":"Schatz","year":"2015","journal-title":"Clin J Pain"},{"key":"10.1016\/j.blre.2024.101194_bb0290","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.7326\/M20-7171","article-title":"Treatment of acute pain in adults with Sickle Cell disease in an infusion center versus the emergency department\u202f: a multicenter prospective cohort study","volume":"174","author":"Lanzkron","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2024.101194_bb0295","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ajh.23961","article-title":"Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis","volume":"90","author":"Lanzkron","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2024.101194_bb0300","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/bloodadvances.2020001743","article-title":"Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects","volume":"4","author":"Kanter","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2024.101194_bb0305","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V95.4.1130.003k03a_1130_1136","article-title":"Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises","volume":"95","author":"Benjamin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2024.101194_bb0310","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2141.2004.05123.x","article-title":"Day case management of sickle pain: 3 years experience in a UK sickle cell unit","volume":"126","author":"Wright","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2024.101194_bb0315","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajem.2017.07.037","article-title":"Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit","volume":"36","author":"Molokie","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.blre.2024.101194_bb0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2141.1999.01160.x","article-title":"Day-care management of sickle cell painful crisis in Jamaica: a model applicable elsewhere?","volume":"104","author":"Ware","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2024.101194_bb0325","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/cer-2021-0257","article-title":"An impact evaluation of two modes of care for sickle cell disease crises","volume":"11","author":"Skinner","year":"2022","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.blre.2024.101194_bb0330","author":"NHS England"},{"key":"10.1016\/j.blre.2024.101194_bb0335","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/1062860619873402","article-title":"Clinical transformation in Care for Patients with Sickle Cell Disease at an urban Academic Medical Center","volume":"35","author":"Rizk","year":"2020","journal-title":"Am J Med Qual"},{"key":"10.1016\/j.blre.2024.101194_bb0340","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/bmj.318.7198.1585","article-title":"Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study","volume":"318","author":"Maxwell","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2024.101194_bb0350","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1186\/s12913-019-4726-5","article-title":"Not being heard: barriers to high quality unplanned hospital care during young people\u2019s transition to adult services - evidence from \u2018this sickle cell life\u2019 research","volume":"19","author":"Renedo","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.blre.2024.101194_bb0355","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.hoc.2022.08.008","article-title":"Structural racism and impact on sickle cell disease: sickle cell lives matter","volume":"36","author":"Smith","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.blre.2024.101194_bb0360","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJMp2022125","article-title":"When actions speak louder than words - racism and sickle cell disease","volume":"383","author":"Power-Hays","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2024.101194_bb0365","author":"Sickle Cell Society"},{"key":"10.1016\/j.blre.2024.101194_bb0370","series-title":"The Sickle Cell guide","author":"Gbangbola","year":"2022"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X24000274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X24000274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:27:07Z","timestamp":1713353227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X24000274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":72,"alternative-id":["S0268960X24000274"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2024.101194","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The acute pain crisis in sickle cell disease: What can be done to improve outcomes?","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2024.101194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101194"}}